Skip to content

Lopinavir/ritonavir equivalent to nevirapine in Ugandan children

New pro-drug tenofovir alafenamide appears equally effective but better tolerated

Andrew Zolopa, Stamford University, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Dosing of key TB drug rifampicin could go higher

Martin Boeree, St Radboud University, Nijmegen, presenting at CROI 2013.

Once-weekly continuation phase TB treatment equals standard of care

Dr Amina Jindani, St George’s University Medical School, London, presenting at CROI 2013.

Continuing cotrimoxazole in children on ART reduces the risk of hospitalisation

Mutsa Bwakura-Dangarembizi presenting at CROI 2013.

In resource-rich countries, migrants have a higher risk of progressing to AIDS in the first year of HIV therapy

Low nadir CD4 cell count associated with increased cataract risk in South Africans taking HIV therapy

Classic characteristics of old age associated with poor physical function in middle-aged people living with HIV

Frailty increases the risk of fragility fractures in men living with HIV: data collected in routine HIV care can help predict risk